Tweet NEW YORK, NY, Elysium Health announced a $40 million in Series C equity and debt financing round.

Since its founding, Elysium Health has been recognized for its commitment to scientific rigor, and the funds will also further the company's mission to make the benefits of scientific research accessible directly to consumers.

"We consider ourselves privileged at Elysium to work with the world's best healthcare investors," said Elysium Health CEO Eric Marcotulli.

We are thrilled to invest in the Elysium Health team to further the work they are doing to change the way people support their lifelong health."

Working directly with the world's leading scientists and clinicians, Elysium Health™ is committed to translating critical advancements in scientific research into health solutions people can access today. | To read full story, visit https://startuparound.com/read/1577493124.5198514/Elysium-Health-Raises-$40M-Series-C?ref=audio_experience